HUP0402098A2 - Baromfibetegségeket okozó új baktérium és ebből származó vakcina - Google Patents

Baromfibetegségeket okozó új baktérium és ebből származó vakcina

Info

Publication number
HUP0402098A2
HUP0402098A2 HU0402098A HUP0402098A HUP0402098A2 HU P0402098 A2 HUP0402098 A2 HU P0402098A2 HU 0402098 A HU0402098 A HU 0402098A HU P0402098 A HUP0402098 A HU P0402098A HU P0402098 A2 HUP0402098 A2 HU P0402098A2
Authority
HU
Hungary
Prior art keywords
bacteria
poultry
mannheimia haemolytica
poultry disease
pasteurella trehalosi
Prior art date
Application number
HU0402098A
Other languages
English (en)
Inventor
Maria Elena Vazquez
Raul Campogarrido
Carlos Gonzales-Hernandez
Vaithianathan Sivanandan
Original Assignee
Boehringer Ingelheim Vetmedica S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica S.A. De C.V. filed Critical Boehringer Ingelheim Vetmedica S.A. De C.V.
Publication of HUP0402098A2 publication Critical patent/HUP0402098A2/hu
Publication of HUP0402098A3 publication Critical patent/HUP0402098A3/hu
Publication of HU228692B1 publication Critical patent/HU228692B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)

Abstract

A találmány az állategészségügy területére, új baromfibetegséget,szárnyasok felső légúti és szaporító szerveinek megbetegedését okozóPasteurella trehalosi és/vagy Mannheimia haemolytica baktériumokraterjed ki. A találmány tárgyát képezik nevezett Pasteurella trehalosiés/vagy Mannheimia haemolytica baktériumok, ezen baktériumokjelenlétének diagnosztizálása beteg szárnyasokból és Pasteurellatrehalosi és/vagy Mannheimia haemolytica baktériumokat tartalmazóvakcina és eljárás csirkék immunizálására nevezett baromfibetegséggelszemben. Ó
HU0402098A 2001-10-26 2002-10-24 Novel bacterial poultry disease HU228692B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit
PCT/EP2002/011899 WO2003037367A2 (en) 2001-10-26 2002-10-24 New bacterium causing poultry disease and vaccine derived thereof

Publications (3)

Publication Number Publication Date
HUP0402098A2 true HUP0402098A2 (hu) 2005-02-28
HUP0402098A3 HUP0402098A3 (en) 2005-07-28
HU228692B1 HU228692B1 (en) 2013-05-28

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402098A HU228692B1 (en) 2001-10-26 2002-10-24 Novel bacterial poultry disease

Country Status (32)

Country Link
US (3) US7794735B2 (hu)
EP (2) EP1942181A1 (hu)
JP (2) JP4447319B2 (hu)
KR (2) KR101024887B1 (hu)
CN (1) CN100471945C (hu)
AR (3) AR037020A1 (hu)
AT (1) ATE391767T1 (hu)
AU (1) AU2002363173B2 (hu)
BR (1) BR0213538A (hu)
CA (1) CA2462652A1 (hu)
CO (1) CO5580796A2 (hu)
CY (1) CY1108178T1 (hu)
DE (2) DE10152307A1 (hu)
DK (1) DK1442114T3 (hu)
EC (1) ECSP045083A (hu)
ES (1) ES2304466T3 (hu)
HK (1) HK1073862A1 (hu)
HR (1) HRP20040366B1 (hu)
HU (1) HU228692B1 (hu)
IL (1) IL161223A0 (hu)
MA (1) MA26293A1 (hu)
MX (1) MXPA04003941A (hu)
MY (1) MY138203A (hu)
NO (1) NO333635B1 (hu)
NZ (1) NZ532805A (hu)
PL (1) PL206589B1 (hu)
PT (1) PT1442114E (hu)
RU (4) RU2430967C2 (hu)
SI (1) SI1442114T1 (hu)
UA (2) UA96948C2 (hu)
WO (1) WO2003037367A2 (hu)
ZA (1) ZA200402499B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
KR20130027448A (ko) * 2009-10-09 2013-03-15 코벤하븐스 유니버시테트 갈리박테리움 아나티스로부터의 세포용해 ｒｔｘ-독소
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
EP2976102B1 (en) 2013-03-18 2019-12-11 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
EP0625190B1 (en) * 1992-10-14 1996-12-27 Akzo Nobel N.V. New bacterium causing poultry disease and vaccine derived thereof
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU94023126A (ru) * 1994-06-16 1997-04-10 Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко Вакцина против пастереллеза свиней
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
WO2001044289A2 (en) * 1999-12-17 2001-06-21 University Of Guelph Office Of The Vice President Of Research Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Also Published As

Publication number Publication date
ZA200402499B (en) 2005-06-08
BR0213538A (pt) 2004-10-19
RU2430967C2 (ru) 2011-10-10
NZ532805A (en) 2008-04-30
UA89607C2 (ru) 2010-02-25
HUP0402098A3 (en) 2005-07-28
DE60226057D1 (de) 2008-05-21
ATE391767T1 (de) 2008-04-15
JP2005511032A (ja) 2005-04-28
EP1442114B1 (en) 2008-04-09
KR20050039688A (ko) 2005-04-29
RU2481393C2 (ru) 2013-05-10
JP2010051324A (ja) 2010-03-11
JP5087604B2 (ja) 2012-12-05
JP4447319B2 (ja) 2010-04-07
MA26293A1 (fr) 2004-09-01
WO2003037367A2 (en) 2003-05-08
KR101024887B1 (ko) 2011-03-31
CN1575334A (zh) 2005-02-02
AR037020A1 (es) 2004-10-20
US20100104594A1 (en) 2010-04-29
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
MXPA04003941A (es) 2004-11-29
US20110212132A1 (en) 2011-09-01
US20090181055A1 (en) 2009-07-16
MY138203A (en) 2009-05-29
DE60226057T2 (de) 2009-05-14
AR067732A2 (es) 2009-10-21
IL161223A0 (en) 2004-09-27
HU228692B1 (en) 2013-05-28
AR073482A2 (es) 2010-11-10
CA2462652A1 (en) 2003-05-08
CO5580796A2 (es) 2005-11-30
DE10152307A1 (de) 2003-05-08
RU2007148219A (ru) 2009-07-10
KR20090083941A (ko) 2009-08-04
RU2007129099A (ru) 2009-02-10
RU2334792C2 (ru) 2008-09-27
HRP20040366A2 (en) 2005-04-30
ES2304466T3 (es) 2008-10-16
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
EP1942181A1 (en) 2008-07-09
DK1442114T3 (da) 2008-06-09
NO20041675L (no) 2004-04-23
PL206589B1 (pl) 2010-08-31
US7964197B2 (en) 2011-06-21
HRP20040366B1 (en) 2012-05-31
PT1442114E (pt) 2008-05-20
ECSP045083A (es) 2004-08-27
EP1442114A2 (en) 2004-08-04
CN100471945C (zh) 2009-03-25
UA96948C2 (ru) 2011-12-26
KR100954175B1 (ko) 2010-04-20
RU2456343C2 (ru) 2012-07-20
RU2008136404A (ru) 2010-03-20
RU2004116134A (ru) 2005-05-10
AU2002363173B2 (en) 2007-09-20
NO333635B1 (no) 2013-07-29
CY1108178T1 (el) 2014-02-12
HK1073862A1 (en) 2005-10-21

Similar Documents

Publication Publication Date Title
Berta et al. Review of the cetacean nose: form, function, and evolution
Bartosiewicz et al. Shuffling nags, lame ducks: The archaeology of animal disease
CY1123050T1 (el) Φαρμακα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
TW200505425A (en) Compositions and method for treating infection in cattle and swine
HK1087949A1 (en) Immunogene adherence and method of making and using the same
CY1105331T1 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
MX2012003827A (es) Toxina rtx citolitica de gallibacterium anatis.
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
Boeskorov et al. The preliminary analysis of cave lion cubs Panthera spelaea (Goldfuss, 1810) from the permafrost of Siberia
HUP0401077A2 (hu) Mycoplasma bovis fertőzési modell, valamint eljárások M. bovis bejuttatására és tüdőgyulladásos tüdőléziók indukálására
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
DE60120425D1 (de) Verfahren zur herstellung von klonierten vögeln
Peruga et al. Orthodontic Treatment of Dogs during the Developmental Stage: Repositioning of Mandibular Canine Teeth with Intercurrent Mandibular Distoclusion
Pal Animal experimentations: Part I: General considerations
TH78298B (th) โรคสัตว์ปีกชนิดใหม่ที่เกิดจากแบคทีเรีย
Kaveh et al. Reducing anthrax infection in man through animal vaccination in Iran
TH78298A (th) โรคสัตว์ปีกชนิดใหม่ที่เกิดจากแบคทีเรีย
ATE473295T1 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
Lamb Dear evil engineer: Should I impress my date by engineering a unicorn?
HUP0100123A2 (hu) Eljárás tojástermelés növelésére és a tojáshéj szilárdítására szárnyasoknál
Бекишева et al. 7.2 The First Signs of Gum Disease

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees